Oxford Gene Technology (OGT) - The Molecular Genetics Company

NGS Products for Haematology and Solid Tumour Cancers

An expanding portfolio of NGS panels for cancer research, and library preparation products for the accurate detection of genetic variants.

NGS and Array Products for Cytogenetics and Rare Disease

A broad range of NGS and array products for constitutional cytogenetics, rare disease, cancer and reproductive health research.

FISH Probes for Cancer and Inherited Genetic Disease

High-quality fluorescence in situ hybridisation (FISH) probes for the detection of gene rearrangements related to cancer and inherited genetic disease research.

News

6 February 2020
Sysmex Inostics and OGT combine in breast cancer FFPE / ctDNA research
Plasma and tissue sequencing demonstrate clearance of ctDNA correlates with pathologic complete response in breast cancer patients during neoadjuvant treatment.
30 January 2020
OGT launches breakthrough NGS panel for constitutional cytogenetics
Robust panel enables accurate and comprehensive constitutional genetic aberration screening in one assay.

More News > News RSS

Browse products by technology

Next Generation Sequencing (NGS) Panels
Microarrays
Fluorescence in situ Hybridisation (FISH) Probes

NGS Products for Haematology and Solid Tumour Cancers

NGS and Array Products for Cytogenetics and Rare Disease

FISH Probes for Cancer and Inherited Genetic Disease

News

Sysmex Inostics and OGT combine in breast cancer FFPE / ctDNA research

OGT launches breakthrough NGS panel for constitutional cytogenetics

Browse products by technology